NCT05190133View on ClinicalTrials.gov

Drug-drug Interaction Study Between UIC201601 and UIC201602

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 28, 2016

Primary Completion Date

August 17, 2016

Study Completion Date

August 17, 2016

Conditions
Healthy
Interventions
DRUG

UIC201602 and co-administration of UIC201601 and UIC201602

"* UIC201602 4 Cap/day for 14 days~* Wash out 21 days~* UIC201601 4 Tab + UIC201602 4 Cap / day for 14 days"

DRUG

UIC201601 and co-administration of UIC201601 and UIC201602

"* UIC201601 4 Tab/day for 7 days~* Wash out 14 days~* UIC201601 4 Tab + UIC201602 4 Cap / day for 14 days"

All Listed Sponsors
lead

Korea United Pharm. Inc.

INDUSTRY

NCT05190133 - Drug-drug Interaction Study Between UIC201601 and UIC201602 | Biotech Hunter | Biotech Hunter